Trailhead Biosystems Competitors and Similar CompaniesClear all
CalciMedica's competitors and similar companies include Palatin Technologies and Acticor Biotech.
 CalciMedica CalciMedica (formerly known as Graybug Vision) is a biotechnology company that develops calcium release-activated calcium (CRAC) channel inhibitors. |  Palatin Technologies Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases. |  Acticor Biotech Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke. | |
Founding Date | Founding Date 2007 | Founding Date 1986 | Founding Date 2013 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations La Jolla, US HQ | Locations East Windsor, US HQ | Locations Paris, FR HQ Paris, FR |
Employees | Employees 1614% increase | Employees 185% decrease | Employees 1711% decrease |
Valuation ($) | Valuation ($) 42.4 m | Valuation ($) 22.5 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($29.6m) (FY, 2025) | Net income ($17.3m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 74.5m | Total funding raised $ 104.2m | Total funding raised $ 33.3m |
For sources of this data, please see the company profile
View Company Profiles
Palatin Technologies
HQ
East Windsor, US
Employees
18↓ 5% decrease
Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases.
View companyActicor Biotech
HQ
Paris, FR
Employees
17↓ 11% decrease
Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke.
View company